Literature DB >> 21796397

A traumatic, high-energy and unstable fracture of the C5 vertebra managed with kyphoplasty: a previously unreported case.

Nasir A Quraishi1, Sherief Elsayed.   

Abstract

Unstable cervical fractures commonly require fusion surgery. We present a case of an unstable cervical fracture (AO classification A2.2) affecting the fifth cervical vertebra which was managed by kyphoplasty to achieve a pain-free, functional and stable outcome. The decision to undertake a kyphoplasty procedure was made in the hope of preserving motion and limiting the degree of future adjacent segment disease. We believe this to be the first case of the use of kyphoplasty to be published in the literature in relation to a traumatic cervical fracture. Additionally, at one-year follow-up the patient reports no pain, a near full range of motion in the cervical spine and no neurological deficit.

Entities:  

Mesh:

Year:  2011        PMID: 21796397      PMCID: PMC3175876          DOI: 10.1007/s00586-011-1858-7

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  13 in total

1.  Transoral vertebroplasty for a fractured C2 aneurysmal bone cyst.

Authors:  Philippe Gailloud; Jean-Baptiste Martin; Alessandro Olivi; Daniel A Rüfenacht; Kieran J Murphy
Journal:  J Vasc Interv Radiol       Date:  2002-03       Impact factor: 3.464

2.  Minimally invasive treatment of C2 odontoid traumatic fracture with transoral percutaneous vertebroplasty.

Authors:  Giovanni Carlo Anselmetti; Daniele Regge; Elena Sardo; Antonio Manca; Stefano Cirillo; Teodoro Meloni; Felicino Debernardi
Journal:  Eur Radiol       Date:  2006-04-27       Impact factor: 5.315

3.  Anterolateral percutaneous vertebroplasty at C2 for lung cancer metastasis and upper cervical facet joint block.

Authors:  Ji-Young Yoon; Tae-Kyun Kim; Kyung-Hoon Kim
Journal:  Clin J Pain       Date:  2008-09       Impact factor: 3.442

4.  Minimally invasive anterior vertebroplasty for C-2 metastatic lesions.

Authors:  Richard Rhiew; Sunil Manjila; Adam Dezure; Monir Tabbosha; Murali Guthikonda; Hazem Eltahawy
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

5.  Distribution and patterns of blunt traumatic cervical spine injury.

Authors:  W Goldberg; C Mueller; E Panacek; S Tigges; J R Hoffman; W R Mower
Journal:  Ann Emerg Med       Date:  2001-07       Impact factor: 5.721

6.  Distractive flexion injuries of the subaxial cervical spine treated with anterior plate alone.

Authors:  Thomas Henriques; Claes Olerud; Antonina Bergman; Halldór Jónsson
Journal:  J Spinal Disord Tech       Date:  2004-02

7.  C2/C3 pathologic fractures from polyostotic fibrous dysplasia of the cervical spine treated with percutaneous vertebroplasty.

Authors:  David Dang; Mirza N Baig; Greg Christoforidis; E Antonio Chiocca; Joshue Gabriel
Journal:  Eur Spine J       Date:  2007-07-31       Impact factor: 3.134

8.  Percutaneous vertebroplasty for eosinophilic granuloma of the cervical spine in a child.

Authors:  Hua-Qiao Tan; Ming-Hua Li; Chun-Gen Wu; Yi-Feng Gu; He Zhang; Chun Fang
Journal:  Pediatr Radiol       Date:  2007-08-18

9.  Percutaneous vertebroplasty for multiple myeloma of the cervical spine.

Authors:  Francisco Mont'Alverne; Jean-Noel Vallée; Remy Guillevin; Evelyne Cormier; Betty Jean; Michelle Rose; José Guilherme Caldas; Jacques Chiras
Journal:  Neuroradiology       Date:  2009-01-06       Impact factor: 2.804

10.  Vertebroplasty as treatment of aggressive and symptomatic vertebral hemangiomas: up to 4 years of follow-up.

Authors:  G Guarnieri; G Ambrosanio; P Vassallo; M G Pezzullo; R Galasso; A Lavanga; R Izzo; M Muto
Journal:  Neuroradiology       Date:  2009-03-17       Impact factor: 2.804

View more
  1 in total

1.  Combined Percutaneous Kyphoplasty/Pediculoplasty by Posterolateral Transpedicular Approach for Painful Cervical Spine Metastases: A Single-Center Prospective Study.

Authors:  Yonghui Xia; Huan Zhai; Xinlei Wang; Yudong Wang; Bo Feng
Journal:  J Pain Res       Date:  2021-06-10       Impact factor: 3.133

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.